Respiratory Virus Coinfection Is a Risk Factor for Adverse Outcomes During Staphylococcus aureus Bacteremia

Open Forum Infectious Diseases 2026 Open access

Read full text
Authors: Katherine Roberts, Simon Dewar, Rebecca Sutherland, Clark D Russell
DOI: 10.1093/ofid/ofag113
Cited by: 0
References: 17

Abstract

ABSTRACT We conducted a retrospective study of adults with Staphylococcus aureus bacteraemia to determine the impact of respiratory virus co-infection. Co-infection, predominantly with SARS-CoV-2, was associated with SAB originating from the respiratory tract (21.1% vs. 5.2%, P =0.002), persistent bacteraemia (13.2% vs . 3.4%, P =0.02) and independently with 30-day mortality (31.6% vs . 18.0%, P =0.04).

Fields of Study & Subjects

Antimicrobial Resistance in Staphylococcus Pneumonia and Respiratory Infections Sepsis Diagnosis and Treatment

Publication details

Journal / source
Open Forum Infectious Diseases
Volume
13
Issue
3
Pages
ofag113–ofag113
Publication date
27 February 2026
Language
EN